New study confirms presence of bifidobacteria and lactobacilli in breast milk from Chinese mothers

New study confirms presence of bifidobacteria and lactobacilli in breast milk from Chinese mothers
Press Release | May 11. 2015 07:13 GMT

A study initiated by Chr. Hansen has shown that bifidobacteria and lactobacilli are present in breast milk from Chinese mothers, strengthening the case for adding clinically documented probiotics to infant formula, in order to improve nutrition.

In the last decade, research has shown that breast milk from Western women contains bacteria, such as bifidobacteria and lactobacilli. Bifidobacteria are known to play an important role in the development of a healthy microbiota in infants and children, which is beneficial to the digestive and immune functions. A new study now confirms a presence of the same bacteria in breast milk from Chinese mothers.

The study was initiated by Chr. Hansen and conducted in collaboration with Shanghai Institute of Pediatric Research. The main author, Dr. Linxi Qian, presented the results last week at the European Society for Pediatric Gastroenterology, Hepatology and Nutrition 2015, in Amsterdam.

Important findings for infant formula development

Chr. Hansen continuously invests in clinical studies within the infant segment, and previous studies have shown that the probiotic Bifidobacterium strain named BB-12® may be effective in preventing gastrointestinal and respiratory infections in infants and children[1]. The product portfolio also includes Lactobacillus,LGG® which is the world’s best documented lactobacillus.

Mikkel Jungersen, Scientific Advisor, Human Health & Nutrition, Chr. Hansen, says: “The confirmed presence of bifidobacteria and lactobacilli in Chinese breast milk is essential knowledge for all those who are active in the infant formula business in China. It makes sense for a mother who is feeding her baby with infant formula to prefer a product resembling real breast milk the most, and this study shows that bifidobacteria and/or lactobacilli are essential additives to nutritious infant formula.”



For more information on the study or on BB-12® or LGG®, please do not hesitate to contact Mikkel Jungersen, +45 22 57 26 78 or DKMKJ@chr-hansen.com.

To read more about Chr. Hansen’s BB-12®, click here.To read more about LGG®, click here.

Note: Chr. Hansen is committed to the highest standards of responsible marketing of breast milk substitutes and complies with the WHO Code as implemented by national governments.

[1]Chouraqui et al. 2004; Saavedra et al. 2004; Saavedra et al. 1994; Taipale et al. 2010 Rautava et al. 2009.


科汉森是为食品、营养、制药和农业行业开发天然解决方案的一家全球领先的生物科学公司。我们为各种食品、糖果、饮料、膳食补充剂、动物饲料和植物保护开发和生产发酵剂、酶、益生菌和天然色素。我们的产品创新基于大约 40,000 株微生物菌株——我们喜欢称之为“有益菌群”。我们的解决方案帮助食品制造商实现以更少的资源生产更多的产品,同时也减少了化学添加剂和其他合成物添加剂的使用,这使得我们的产品与当今世界息息相关。可持续性是科汉森改善食物和健康的愿景不可分割的一部分。2019 年,科汉森被 Corporate Knights 评为全球最可持续发展的公司,这要归功于我们为可持续发展付出的巨大努力以及我们与客户建立的众多合作伙伴关系。145 年来,我们一直在不断地为我们的合作伙伴以及全球终端消费者创造价值。令我们感到自豪的是,每天有超过 10 亿人在消费含有我们天然成分的产品。科汉森成立于 1874 年,并已在哥本哈根证券交易所上市。

NewsAttachments

共享